Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)
Maschmeyer, Georg (Klinikum Ernst von Bergmann)
De Greef, Julien (Henri Mondor Teaching Hospital)
Mellinghoff, Sibylle C. (University of Cologne)
Nosari, Annamaria (ASST Grande Ospedale Metropolitano Niguarda)
Thiebaut-Bertrand, Anne (Université Grenoble Alpes)
Bergeron, Anne (APHP Saint-Louis Hospital)
Franquet, Tomas (Institut d'Investigació Biomèdica Sant Pau)
Blijlevens, Nicole M.A. (Radboud University Medical Centre)
Maertens, Johan A. (Katholieke Universiteit te Leuven (1970-))
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau)
Universitat Autònoma de Barcelona

Date:	2019
Abstract:	A multitude of new agents for the treatment of hematologic malignancies has been introduced over the past decade. Hematologists, infectious disease specialists, stem cell transplant experts, pulmonologists and radiologists have met within the framework of the European Conference on Infections in Leukemia (ECIL) to provide a critical state-of-the-art on infectious complications associated with immunotherapeutic and molecular targeted agents used in clinical routine. For brentuximab vedotin, blinatumomab, CTLA4- and PD-1/PD-L1-inhibitors as well as for ibrutinib, idelalisib, HDAC inhibitors, mTOR inhibitors, ruxolitinib, and venetoclax, a detailed review of data available until August 2018 has been conducted, and specific recommendations for prophylaxis, diagnostic and differential diagnostic procedures as well as for clinical management have been developed.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Epidemiology ; Immunopathogenesis
Published in:	Leukemia, Vol. 33 Núm. 4 (january 2019) , p. 844-862, ISSN 1476-5551

DOI: 10.1038/s41375-019-0388-x
PMID: 30700842

19 p, 824.2 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles